Astrana Health Inc

Astrana Health Inc

ASTH · NASDAQ · Healthcare / Medical Care Facilities

31.80USD+0.03 (+0.09%)

Price History

Full chart

Market Stats

Previous Close31.77
Open31.61
Day Range30.84 – 32.66
52-Week Range18.08 – 51.60
Volume297.20K
Market Cap1.80B
P/E (TTM)44.35
Forward P/E8.97
EPS0.82
Dividend Yield0.00%
Beta0.91
50-Day Avg38.09
200-Day Avg32.28

About

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEOMr. Brandon K. Sim M.S.
  • Employees3.00K
  • Headquarters1668 S. Garfield Avenue, Alhambra, CA, United States, 91801, USA
  • Websitehttps://www.astranahealth.com

Leadership

  • Dr. Kenneth T. Sim F.A.C.S., M.D.Co-Founder & Executive Chairman · b. 1954
  • Mr. Brandon K. Sim M.S.President & CEO · b. 1994
  • Dr. Thomas S. Lam M.D., M.P.H.Co-Founder & Vice Chairman · b. 1949
  • Mr. Chandan Basho M.B.A.CFO, COO & Corporate Secretary · b. 1983
  • Mr. John Vong CPA, CGMA, M.B.A.Senior VP of Accounting & Principal Accounting Officer · b. 1973
  • Ms. Rita Pew M.B.A.Chief People Officer
  • Dr. WaiChow Young M.D., M.P.H.Senior Vice President of Health Affairs · b. 1948
  • Dr. Jeremy R. Jackson M.D.Chief Quality Officer
  • Ms. Jaime Melkonoff M.B.A.President of AstranaCare - Texas
  • Mr. Paul Van Duine M.B.A.Senior Vice President of Contracting

Financials

Income Statement

Currency: USD2001-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-----100.00K1.06M2.44M3.90M5.11M7.78M10.48M32.99M44.05M57.43M357.75M519.91M560.62M370.25M773.91M1.14B1.39B2.03B3.18B
Growth (%)------+957.35%+130.90%+59.60%+31.16%+52.15%+34.83%+214.66%+33.52%+30.37%+522.95%+45.33%+7.83%-33.96%+109.03%+47.84%+21.19%+46.72%+56.39%
Cost of Revenue-----100.00K1.05M1.81M3.31M4.13M6.32M9.08M22.07M34.35M48.74M293.73M380.44M467.81M348.54M596.14M944.68M1.17B1.76B2.89B
Gross Profit------11.25K627.51K581.86K978.41K1.46M1.41M10.92M9.70M8.69M64.02M139.47M92.81M21.70M177.77M199.48M214.96M271.39M295.78M
Gross Margin------1.06%25.70%14.93%19.14%18.77%13.43%33.11%22.01%15.14%17.89%26.83%16.56%5.86%22.97%17.43%15.50%13.34%9.30%
Operating Expense------847.07K730.02K577.85K1.39M3.54M5.32M11.62M16.28M19.23M26.44M47.24M60.39M15.62M79.59M95.21M130.34M182.04M217.26M
Operating Income-4.96K-7.80K-10.09K-13.34K-27.48K-36.65K-835.82K-102.52K4.01K-413.33K-2.08M-3.91M-694.33K-6.58M-10.54M37.58M92.23M32.42M6.09M98.18M104.27M84.61M89.35M78.53M
Operating Margin------36.65%-79.05%-4.20%0.10%-8.09%-26.73%-37.29%-2.10%-14.94%-18.35%10.50%17.74%5.78%1.64%12.69%9.11%6.10%4.39%2.47%
EBITDA--7.80K-10.09K-13.34K-27.48K-36.65K-816.03K-66.81K15.21K-397.90K-2.09M-3.83M-359.90K-7.35M-9.88M68.87M102.49M48.85M29.74M100.66M112.08M123.69M141.84M135.28M
EBITDA Margin------36.65%-77.18%-2.74%0.39%-7.79%-26.94%-36.52%-1.09%-16.69%-17.20%19.25%19.71%8.71%8.03%13.01%9.80%8.92%6.97%4.25%
Net Income-4.96K-7.80K-10.09K-13.34K-27.48K-36.65K-891.82K-196.08K-156.33K-720.35K-8.90M-5.02M-1.80M-9.34M-8.97M25.80M10.84M14.12M-23.75M68.92M45.17M60.72M43.15M22.49M
Net Income Margin------36.65%-84.34%-8.03%-4.01%-14.09%-114.51%-47.88%-5.46%-21.21%-15.62%7.21%2.08%2.52%-6.42%8.91%3.95%4.38%2.12%0.71%
R&D---------00000000-------
R&D as % of Total Revenue---------0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-------
Interest Expense07.80K10.09K13.34K27.48K36.65K55.20K53.13K126.43K304.03K930.18K679.18K0542.30K82.91K79.69K560.51K4.73M2.53M5.39M7.92M16.10M33.10M49.93M
Interest Expense % of Total Revenue-----36.65%5.22%2.18%3.24%5.95%11.96%6.48%0.00%1.23%0.14%0.02%0.11%0.84%0.68%0.70%0.69%1.16%1.63%1.57%

Balance Sheet

Currency: USD2001-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets347352124912100.00K414.23K1.31M1.26M1.36M3.22M9.48M9.48M19.57M20.64M490.64M513.00M728.71M817.49M867.36M966.21M933.36M1.35B2.22B
Total Liabilities34731.53K41.39K54.62K82.10K117.74K655.14K1.35M1.34M1.79M3.61M11.11M11.11M11.02M20.37M154.32M106.34M367.65M372.34M356.72M407.67M522.59M840.73M1.66B
Total Equity0-31.18K-41.27K-54.61K-82.09K-17.74K-240.91K-46.39K-83.19K-421.22K-391.38K-1.62M-1.62M5.81M270.37K159.95M180.55M191.55M330.82M448.17M542.56M614.22M712.72M779.29M
Cash347352124912-84.16K665.74K397.10K164.36K1.18M6.83M6.83M9.27M8.66M119.77M106.89M103.19M193.47M233.10M288.03M293.81M288.45M429.47M
Total Debt---39.26K55.22K67.32K306.00K1.25M1.25M746.37K2.50M6.75M8.14M188.76K9.89M6.25M13.66M256.55M260.56M200.98M229.36M321.01M471.84M1.08B
Net Debt-347-352-12439.25K55.21K67.32K221.84K581.85K851.49K582.00K1.33M-79.17K-79.17K-9.08M1.23M-113.52M-93.23M153.36M67.08M-32.11M-58.66M27.21M183.38M648.66M

Cash Flow

Currency: USD2001-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-393-6.14K-228-6.16K-15.96K-13.11K-635.58K-338.14K-245.03K-385.45K57.96K-1.48M-271.91K-1.84M-8.14M53.07M26.10M13.67M46.16M70.33M82.13M68.23M52.20M114.60M
Investing Cash Flow---------157.00K-31.68K-272.93K-3.20M-247.11K-1.39M6.73M-25.76M-180.63M95.49M16.54M-7.11M-65.52M-192.40M-539.00M
Financing Cash Flow-6.00K-6.05K15.96K13.10K656.10K919.72K-2.44K-4.29K986.10K2.03M1.66M6.34M8.92M-14.98M-11.20M163.33M-51.70M-47.75M-20.09M3.42M135.15M569.35M
Capital Expenditure0000000021.16K7.21K45.80K22.93K44.51K262.11K297.56K2.08M1.17M1.04M1.16M19.22M22.94M28.53M8.03M10.11M
Free Cash Flow-393-6.14K-228-6.16K-15.96K-13.11K-635.58K-338.14K-266.20K-392.66K12.16K-1.50M-316.42K-2.10M-8.44M50.99M24.93M12.63M45.00M51.11M59.19M39.70M44.17M104.49M
Dividends Paid---------154.29K400.00K240.00K600.00K600.00K1.20M10.45M17.76M61.72M51.32M31.09M14.03M62.07M4.04M7.88M
FCF to OCF100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%108.64%101.87%20.98%101.55%116.37%114.25%103.66%96.07%95.52%92.38%97.48%72.67%72.07%58.19%84.61%91.18%
Dividend Paid to FCF----------39.29%3290.29%-15.99%-189.62%-28.55%-14.22%20.49%71.23%488.59%114.04%60.83%23.70%156.37%9.14%7.55%

Earnings

Report DateDec 31, 2006Mar 31, 2007Jun 30, 2007Sep 30, 2007Dec 31, 2007Apr 30, 2008Jul 31, 2008Oct 31, 2008Jan 31, 2009Apr 30, 2009Jul 31, 2009Oct 31, 2009Jan 31, 2010Apr 30, 2010Jul 31, 2010Oct 31, 2010Jan 31, 2011Apr 30, 2011Jul 31, 2011Oct 31, 2011Jan 31, 2012Apr 30, 2012Jul 31, 2012Oct 31, 2012Jan 31, 2013Apr 30, 2013Jul 31, 2013Oct 31, 2013Jan 31, 2014Jun 30, 2014Sep 30, 2014Feb 25, 2015Aug 21, 2015Nov 17, 2015Mar 2, 2016Aug 15, 2016Aug 14, 2017Nov 14, 2017May 15, 2018Aug 14, 2018Nov 14, 2018Mar 18, 2019May 10, 2019Aug 9, 2019Nov 7, 2019Mar 12, 2020May 27, 2020Aug 7, 2020Nov 4, 2020Mar 10, 2021May 5, 2021Aug 5, 2021Nov 4, 2021Feb 24, 2022May 5, 2022Aug 4, 2022Nov 3, 2022Feb 23, 2023May 8, 2023Aug 7, 2023Nov 7, 2023Feb 27, 2024May 7, 2024Aug 7, 2024Nov 7, 2024Feb 25, 2025May 8, 2025Aug 7, 2025Nov 6, 2025Mar 2, 2026May 7, 2026Aug 6, 2026Nov 5, 2026
EPS Estimate--------------------------------------0.040.100.090.120.080.050.140.200.040.070.220.180.220.210.270.270.320.200.32-0.090.460.350.320.150.290.560.380.210.330.360.610.100.650.310.44
EPS Actual-0.46-0.67-0.51-0.04-0.03-0.01-0.15-0.13-0.06-0.050.01-0.03-0.00-0.00-0.02-0.01-0.02-0.08-0.040.02-0.15-0.05-1.03-1.41-0.24-0.24-0.43-0.27-0.28-0.340.25-0.350.04-0.51-0.31-0.79-0.76-0.640.060.070.24-0.010.000.090.140.180.110.270.290.270.300.280.450.300.310.250.56-0.060.310.280.470.260.640.450.420.370.440.190.670.420.740.40-
Surprise--------------------------------------50.00%-30.00%166.67%-108.33%-95.38%80.00%0.00%-10.00%175.00%285.71%31.82%50.00%36.36%33.33%66.67%11.11%-3.13%25.00%75.00%33.33%-32.61%-20.00%46.88%73.33%120.69%-19.64%10.53%71.82%33.33%-47.22%9.84%307.98%13.85%29.03%-
Timing-----------------------------------After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap1.80B
Enterprise Value2.28B
Trailing P/E44.35
Forward P/E8.97
PEG Ratio0.00
Price / Sales0.47
Price / Book2.05
EPS0.82
Book Value16.87
Revenue (TTM)3.84B
Gross Profit (TTM)402.00M
EBITDA174.91M
Profit Margin1.06%
Operating Margin3.53%
Return on Equity6.90%
Return on Assets3.76%
Shares Outstanding49.60M
Shares Float38.83M
Beta0.91
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 12 analystsTarget 51.67
  • Strong Buy
    9
  • Hold
    3

Ownership Breakdown

Institutions
66.12%
Insiders
22.81%
Retail / Other
11.07%

Top Institutional Holders

  • BlackRock Inc
    6.16M12.43%
  • Vanguard Portfolio Management, LLC
    2.28M4.59%
  • Vanguard Capital Management, LLC
    1.71M3.45%
  • State Street Corp
    1.65M3.33%
  • 325 Capital LLC
    1.61M3.25%
  • Dimensional Fund Advisors, Inc.
    1.47M2.96%
  • Wellington Management Company LLP
    1.29M2.61%
  • Geode Capital Management, LLC
    1.04M2.09%
  • 683 Capital Management LLC
    700.00K1.41%
  • Charles Schwab Investment Management Inc
    644.17K1.30%
  • Bank of America Corp
    574.73K1.16%
  • Ameriprise Financial Inc
    551.60K1.11%
  • Hotchkis & Wiley Capital Management LLC
    481.52K0.97%

Top Fund Holders

  • iShares Core S&P Small-Cap ETF
    2.59M5.21%
  • Vanguard MStar Total Stk Mkt Idx Invest
    1.42M2.86%
  • iShares Russell 2000 ETF
    1.17M2.36%
  • Vanguard Small Cap Index
    1.02M2.07%
  • Vanguard MStar Small Cap Growth Indx Inv
    587.22K1.18%
  • Fidelity Small Cap Index
    494.53K1.00%
  • Diamond Hill Small Cap Inv
    491.12K0.99%

Stock Splits

  • Apr 27, 20151:10